chr17-78484959-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_173628.4(DNAH17):āc.7558T>Gā(p.Phe2520Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,613,166 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0023 ( 1 hom., cov: 31)
Exomes š: 0.0028 ( 6 hom. )
Consequence
DNAH17
NM_173628.4 missense
NM_173628.4 missense
Scores
5
5
4
Clinical Significance
Conservation
PhyloP100: 9.18
Genes affected
DNAH17 (HGNC:2946): (dynein axonemal heavy chain 17) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. DNAH17 is a heavy chain associated with axonemal dynein (Milisav and Affara, 1998 [PubMed 9545504]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.02804926).
BP6
Variant 17-78484959-A-C is Benign according to our data. Variant chr17-78484959-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2234915.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00227 (346/152286) while in subpopulation NFE AF= 0.00319 (217/68018). AF 95% confidence interval is 0.00284. There are 1 homozygotes in gnomad4. There are 192 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH17 | NM_173628.4 | c.7558T>G | p.Phe2520Val | missense_variant | 48/81 | ENST00000389840.7 | NP_775899.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH17 | ENST00000389840.7 | c.7558T>G | p.Phe2520Val | missense_variant | 48/81 | 5 | NM_173628.4 | ENSP00000374490.6 |
Frequencies
GnomAD3 genomes AF: 0.00227 AC: 346AN: 152168Hom.: 1 Cov.: 31
GnomAD3 genomes
AF:
AC:
346
AN:
152168
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00238 AC: 586AN: 246670Hom.: 4 AF XY: 0.00234 AC XY: 314AN XY: 134128
GnomAD3 exomes
AF:
AC:
586
AN:
246670
Hom.:
AF XY:
AC XY:
314
AN XY:
134128
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00278 AC: 4062AN: 1460880Hom.: 6 Cov.: 32 AF XY: 0.00262 AC XY: 1902AN XY: 726636
GnomAD4 exome
AF:
AC:
4062
AN:
1460880
Hom.:
Cov.:
32
AF XY:
AC XY:
1902
AN XY:
726636
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00227 AC: 346AN: 152286Hom.: 1 Cov.: 31 AF XY: 0.00258 AC XY: 192AN XY: 74468
GnomAD4 genome
AF:
AC:
346
AN:
152286
Hom.:
Cov.:
31
AF XY:
AC XY:
192
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
9
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
25
ExAC
AF:
AC:
293
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The c.7558T>G (p.F2520V) alteration is located in exon 48 (coding exon 47) of the DNAH17 gene. This alteration results from a T to G substitution at nucleotide position 7558, causing the phenylalanine (F) at amino acid position 2520 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
DNAH17-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | DNAH17: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
PrimateAI
Uncertain
T
REVEL
Uncertain
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at